Search This Blog

Wednesday, July 3, 2013

Lilly to Host Conference Call to Discuss Trial Design of New Solanezumab Phase 3 Study (NYSE:LLY)

Lilly to Host Conference Call to Discuss Trial Design of New Solanezumab Phase 3 Study (NYSE:LLY)

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.